Completion of the Quarterly Tender Offer

Summary by AI ^BETAClose X

CT Healthcare Trust plc has completed its quarterly tender offer, repurchasing 8,386,370 ordinary redeemable shares, which will be held in treasury. Following this transaction, the company now holds 268,150,638 shares in treasury, with 47,001,671 shares remaining in issue. Payment to shareholders for the tendered shares will be made within ten business days of the announcement.

Disclaimer*

CT Healthcare Trust PLC

17 June 2026

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

CT Healthcare Trust plc (the "Company")

Completion of Quarterly Tender Offer

17 June 2026

Further to the quarterly tender offer launched by the Company on 14 May 2026 (the "Tender Offer") for up to 15 per cent. of the Company's issued Shares (excluding any Shares held in treasury), the Company announces that it has acquired 8,386,370 ordinary redeemable shares of £0.01 each in the capital of the Company (the "Shares") pursuant to the Tender Offer. All Shares repurchased by the Company will be held in treasury.

Payment to shareholders of the Tender Offer consideration will be made as soon as practicable, and by no later than 10 Business Days, following the date of this announcement.

Following the above transaction, the Company holds 268,150,638 of its Shares in treasury and has 47,001,671 Shares in issue (excluding treasury shares).

For further information, please contact:

CT Healthcare Trust plc
Sarah MacAulay, Chairman
Columbia Threadneedle Investments	+44 (0) 207 464 5000
Marrack Tonkin, Head of Investment Trusts
JP Morgan Cazenove	+44 (0) 20 3493 8000
William Simmonds / Rupert Budge
Company Secretary Scott McEllen, Columbia Threadneedle Investment Business Limited	+44 (0) 131 573 8372

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END